Evolving diagnosis of HRS - J of Hepatology - Jan.26
The evolving diagnosis of hepatorenal syndrome–acute kidney injury (HRS-AKI) has been a significant topic of discussion in hepatology, nephrology, and critical care, particularly as newer insights challenge traditional diagnostic protocols. Historically, the diagnosis of HRS-AKI has relied heavily on rigid protocols, such as mandatory administration of albumin over a fixed period and adherence to absolute serum creatinine thresholds. These approaches were developed during a time when the understanding of acute kidney injury (AKI) in cirrhosis was relatively limited. However, advances in medical research and clinical care have revealed the complexities of AKI in cirrhosis, including dynamic physiological changes, overlapping mechanisms of kidney injury, and the need for more nuanced, multidisciplinary approaches.
Problem Statement:
The traditional diagnostic framework for HRS-AKI presents several challenges:
Rigid Protocols: Mandatory empiric albumin administration and fixed serum creatinine thresholds may not account for the diverse phenotypes of kidney injury in cirrhosis. This approach risks misclassification, delays in appropriate therapy, and unnecessary harm to patients who may be euvolemic or volume overloaded.
Overlooking Complexity: Dichotomizing HRS-AKI and acute tubular necrosis fails to acknowledge diagnostic uncertainty and the overlapping pathophysiology of these conditions.
Disadvantaged Populations: The reliance on absolute creatinine cutoffs disproportionately affects vulnerable populations, including women, older adults, and individuals with sarcopenia.
Limited Multidisciplinary Input: Excluding key specialties like nephrology and critical care from guideline development restricts the ability to address the full spectrum of AKI in cirrhosis.
Conclusion:
A protocol-driven approach to diagnosing HRS-AKI no longer aligns with the evolving understanding of kidney injury in cirrhosis. Evidence supports a shift towards precision-based care that emphasizes individualized clinical judgment, early reassessment of volume status, multidisciplinary collaboration, and physiologically guided fluid management. This transition aims to enable timelier diagnoses, more appropriate therapies, and reduced risks of preventable harm. Moving away from historical dogma and embracing personalized clinical decision-making represents a necessary evolution in the care of patients with cirrhosis and acute kidney injury. These advancements underscore the importance of adapting diagnostic frameworks to reflect current scientific knowledge and patient-centered care principles.
